” The ASTar system represents an exciting innovative platform with potential for significantly decreasing the interval to antimicrobial optimization in blood stream infections. The potential clinical impact is greatest in pathogens with unpredictable antibiograms like those we encounter locally in our Gram-negative pathogens. Its impressive performance is also combined with ease-of-use and low hands-on-time for the lab technician which are benefits that are often overlooked.
The demonstrable rapid clinical interventions can deliver significant benefits for individual patients and healthcare organizations in terms of quality of care, patient safety, antimicrobial stewardship, and infection prevention measures.”
-Stephen P Kidd, Lead Healthcare Scientist, PhD, Hampshire Hospitals NHS Foundation Trust